88IV - PR Newswire Asia's news


OncoBayes progressing OB-001 to tackle ADC resistance and TKI brain penetration LONDON , Oct. 7, 2026 /PRNewswire/ -- OncoBayes, a privately held clinical-stage pharmaceutical company, today announced the successful completion of preclinical work with OB-001, demonstrating the product's ... 2026-10-07T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
XtalPi Debuts Kodexia™, the World's First Closed-Loop siRNA Platform Combining Generative AI with First-Principles Modeling This unified platform integrates sequence design, chemical modification, experimental validation, extrahepatic delivery design, and intellectual property strategy into an integrated computational–experimental ... 2026-10-06T Biotechnology Health Care/Hospital Medical Equipment
Hisun Pharmaceutical Celebrates 70th Anniversary with Global Partners at Milan-Taizhou Night MILAN , Oct. 6, 2026 /PRNewswire/ -- Zhejiang Hisun Pharmaceutical Co., Ltd. hosted its 70th Anniversary Global Partners Appreciation Dinner in Milan on October 5, the eve of CPHI Milan 2026. Themed ... 2026-10-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Werfen Launches QUANTA Link® 5.0: A Modern, Web-Based Platform for Autoimmune Laboratory Workflow Management A flexible, browser-based solution, QUANTA Link 5.0 centralizes autoimmune testing workflows. It enhances usability, streamlines workflows, and supports confident decision-making in today's autoimmune ... 2026-10-06T Biotechnology Computer Software Computer/Electronics Health Care/Hospital
/C O R R E C T I O N -- Piramal Pharma Solutions/ In the news release, Piramal Pharma Solutions Launches New Microbiology Laboratory at Its Lexington, KY Sterile Injectable Facility, issued 06-Oct-2026 by Piramal Pharma Solutions over PR Newswire, we ... 2026-10-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lundbeck presents Phase Ib data for Lu AF28996 in advanced Parkinson's disease, as Phase II trial begins Results from an 18-week, open-label Phase Ib trial of investigational Lu AF28996 in people with advanced Parkinson's disease are being presented at MDS 2026 The trial provided initial safety and tolerability ... 2026-10-06T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Dr. Oregonin Completes U.S. FDA Registration for OLTIS DENTAL-X, Unveiling Oral-Care Innovation Rooted in Trans-Pacific Alder Research Botanical oral-care product bridges 1974 Oregon State University discovery of 'oregonin' with 27 years of natural-product research by South Korean scientists. ... 2026-10-06T Biotechnology Cosmetics & Personal Care Health Care/Hospital
CHANDO Group Presents 20 Research Papers at IFSCC 2026 Congress in Perth 12 years of participation underscore the Group's growing presence in global cosmetics science ... 2026-10-06T Biotechnology Cosmetics & Personal Care Household/Consumer/Cosmetics Medical/Pharmaceuticals
Fapon Showcases High-Performance IVD Raw Materials at JACLaS EXPO 2026 KOBE, Japan , Oct. 6, 2026 /PRNewswire/ -- Fapon, a trusted global IVD provider, will showcase its one-stop IVD solution at JACLaS EXPO 2026, held October 8–10 in Kobe, Japan. Visit Booth B32, Hall 1, ... 2026-10-06T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
EpiSign and Geneyx Announce Partnership to Integrate Genomic and Epigenomic Analysis for Rare Disease Collaboration brings EpiSign's comprehensive DNA methylation episignature analysis together with the Geneyx genomic and multi-omics analysis platform ... 2026-10-05T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology